Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2022
Has the Enemy "MET" Its Match? Subgroup Analysis Results from VISION StudySamuel Rosner, Alexander I SpiraJournal for Immunotherapy of Cancer|April 22, 2017
Response after treatment with pembrolizumab in a patient with myelophthisis due to melanoma: the role of checkpoint inhibition in the boneSamuel Rosner, Filiz Sen, Michael PostowAnnual Review of Medicine|October 26, 2018
PD-1 Blockade in Early-Stage Lung CancerSamuel Rosner, Joshua E Reuss, Patrick M FordeClinical Advances in Hematology & Oncology : H&O|May 28, 2024
Antibody-drug conjugates in advanced lung cancer: Is this a new frontier?Joshua E Reuss, Samuel Rosner, Benjamin P LevyJTO Clinical and Research Reports|September 19, 2022
Association of Pathologic Complete Response and Long-Term Survival Outcomes Among Patients Treated With Neoadjuvant Chemotherapy or Chemoradiotherapy for NSCLC: A Meta-AnalysisSamuel Rosner, Chunnan Liu, Patrick M Forde, et al.Future Oncology (London, England)|May 3, 2023
Adagrasib: a novel inhibitor for <i>KRAS</i>-mutated non-small-cell lung cancerMatthew Z Guo, Kristen A Marrone, Alexander Spira, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 21, 2023
Neoadjuvant Immunotherapy for Non-Small Cell Lung CancerKhaled Sanber, Samuel Rosner, Patrick M Forde, et al.Journal for Immunotherapy of Cancer|December 18, 2020
Immune-mediated ototoxicity associated with immune checkpoint inhibitors in patients with melanomaSamuel Rosner, Yuri Agrawal, Daniel Q Sun, et al.Frontiers in Oncology|August 12, 2025
Case Report: Pathologic complete response in a patient with simultaneous diagnoses of resectable NSCLC and myeloid neoplasm with PDGFRA rearrangement treated with concurrent neoadjuvant chemoimmunotherapy and imatinib: translating clinical trial data to real-world practiceChad B Sussman, Minal Shah, Kausha Amin, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 10, 2023
Antibody-Drug Conjugates for Lung Cancer: Payloads and ProgressSamuel Rosner, Augusto Valdivia, Hui Jing Hoe, et al.Pageof 3